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Aims Considerable shortcomings in the treatment of myocardial infarction (MI) still exist and therefore mortality remains
high. Cardiac stem cell (CSC) therapy is a promising approach for myocardial repair. However, identification and iso-
lation of candidate CSCs is mainly based on the presence or absence of certain cell surface markers, which suffers
from some drawbacks. In order to find a more specific and reliable identification and isolation method, we investi-
gated whether CSCs can be isolated based on the high expression of aldehyde dehydrogenase (ALDH).
Methods
and results
An ALDH+ stem cell population, the cardiac atrial appendage stem cells (CASCs), was isolated from human atrial
appendages. CASCs possess a unique phenotype that is clearly different from c-kit+ CSCs but that seems more
related to the recently described cardiac colony-forming-unit fibroblasts. Based on immunophenotype and in vitro
differentiation studies, we suggest that CASCs are an intrinsic stem cell population and are not mobilized from
bone marrow or peripheral blood. Indeed, they possess a clonogenicity of 16% and express pluripotency-associated
genes. Furthermore, compared with cardiosphere-derived cells, CASCs possess an enhanced cardiac differentiation
capacity. Indeed, differentiated cells express the most important cardiac-specific genes, produce troponin T proteins,
and have an electrophysiological behaviour similar to that of adult cardiomyocytes (CMs). Transplanting CASCs in the
minipig MI model resulted in extensive cardiomyogenic differentiation without teratoma formation.
Conclusion We have identified a new human CSC population able to differentiate into functional CMs. This opens interesting
perspectives for cell therapy in patients with ischaemic heart disease.
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1. Introduction
Stem cell therapy is a novel approach to restore cardiac function after
myocardial infarction (MI). Over the last decade, the results of clinical
trials involving either intracoronary or intramyocardial transplant of
bone marrow (BM)-derived stem cells have been published. The
minor improvement of cardiac function reported1,2 may be explained
by the limited cardiomyogenic differentiation potential of BM-derived
stem cells.3,4 Nevertheless, transplantation of BM-derived mesenchy-
mal stem cells (MSCs) can be beneficial because it can promote the
survival of cardiomyocytes (CMs) through paracrine effects.5 To
develop more successful stem-cell therapies, the scientific focus has
shifted from BM-derived stem cells to cardiac stem cells (CSCs)
because they are probably programmed to become CMs. The pres-
ence of a multipotent endogenous c-kit+ CSC population was first
described in rats6 and later in humans.7 Since then, several groups
have reported the isolation of CSCs expressing a variety of other
markers or functional properties, e.g. islet-1,8 Sca-1,9 cardiac side
population cells,10 and cardiosphere-derived cells (CDCs).11 Despite
initial promising in vitro and pre-clinical research data, the first
reported clinical trial with CDCs demonstrated no significant
change in cardiac function,12 making further investigation necessary.
To date, two methods have mainly been used to isolate human
CSCs: either based on the presence of the c-kit receptor7 or on
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the formation of cardiospheres and subsequent outgrowth cells,
referred to as CDCs.11 Although isolation of stem cells based on
surface antigens has proved to be useful, some limitations arise
when cells are isolated based on their phenotypic profile. For in-
stance, the antigen–antibody interaction is susceptible to non-specific
binding and strict purity controls are necessary to isolate a pure c-kit+
cell population. More importantly, c-kit is not a unique CSCs marker
but is also expressed on hematopoietic stem cells (HSCs) and mast
cells, which have been shown to be present in the adult human
heart.13 Furthermore, it cannot be excluded that antibody binding
to its receptor influences the cellular properties. Therefore, other re-
search groups have started using CDCs obtained by the functional
characteristic of stem cells to generate cardiospheres. However, this
isolation method requires a laborious protocol making it rather un-
attractive for general clinical use. Moreover, sphere formation
seems not to be a unique stem-cell characteristic,14,15 making it unre-
liable as a stand-alone stem-cell isolation technique. Therefore, the
search for new, efficient, and consistent isolation methods is required.
A promising strategy for purifying viable stem cells from tissues is
based on the aldehyde dehydrogenase (ALDH) enzymatic reaction
mechanism. High ALDH activity has already been attributed an im-
portant feature of several stem-cell types including mesenchymal,
neural and recently also cancer stem cells.16–18 By using ALDH as
an isolation marker, we identified a new ALDH+CD34+CD452 stem-
cell population in human atrial appendages with superior cardiomyo-
genic differentiation capacity. Because we believe that these cardiac-
derived ALDH+CD34+CD452 cells are probably an intrinsic cell
population that is clearly distinct from the previously described
c-kit+ CSCs7, we named these cells cardiac atrial appendage stem
cells (CASCs). The identification of this new CASC population
in human heart tissue opens interesting perspectives for cell therapy
in patients with ischaemic heart disease.
2. Material and methods
All procedures were carried out in accordance with the principles set
forth in the Helsinki Declaration. Approval by the institutional review
board and informed consent from each patient were obtained. All
animal studies were approved by the Hasselt University Institutional
Animal Care and Use Committee.
2.1 Isolation and expansion of CASCs from
adult human heart tissue
Right atrial appendages were removed during cardiac surgery. The heart
tissue was minced, washed, enzymatically dissociated, and stained with
Aldefluorw and antibodies according to manufacturer’s instructions.
ALDH+ cells expressing CD34 but negative for CD45 were directly
flow sorted in foetal calf serum (FCS) (n ¼ 90). After isolation, cells
were seeded in fibronectin-coated culture plates and expanded in
X-Vivo 15 medium supplemented with 20% FCS and 2% penicillin–
streptomycin (pen-strep).
2.2 Histological analysis of freshly isolated
CASCs and c-kit1 CSCs
For cytospins of freshly isolated CASCs and c-kit+ CSCs, a minimum of
1.103 cells had to be isolated by flow sorting as previously described.
Cytospins were stained with a May-Gru¨nwald Giemsa staining.
2.3 Isolation of CDCs
CDC isolation was performed as previously described but with minor
modifications.11,15
2.4 Determination of antigen expression
profile of non-expanded and ex vivo expanded
CASCs and CDCs
Single-cell suspensions from heart tissue were incubated with Aldefluorw,
and subsequently stained for 30 min in the dark with the antibodies listed
in Supplementary material online, Table S1 (n ¼ 5). After ex vivo expansion
of CASCs and CDCs, cells were trypsinized and 1 × 105 cells/tube were
incubated with the same set of antibodies. Flowcytometry was performed
on a FACSAriaw.
2.5 Flow cytometric analysis of BM and
peripheral blood ALDH1 cells
BM was aspirated from patients’ sternum before cardiac surgery. The
mononuclear cell (MNC) fraction was isolated.4 The flow cytometric ana-
lysis of peripheral blood ALDH+ cells was performed after a red blood
cell lysis. For both samples, 5 × 106 cells were dissolved in 1 ml Aldefluor
assay buffer, after which they were incubated and analysed (n ¼ 6).
2.6 Functional comparison between
BM-derived ALDH1 cells and CASCs
ALDH+ cells from BM and heart tissue were stained, isolated, and
expanded ex vivo as described above. When sufficient cell numbers
were obtained, both cell types were forced to differentiate into adipo-
cytes and osteocytes (n ¼ 3). HSC cultures were set up by isolating
ALDH+ cells directly from BM or heart tissue, followed by immediate
seeding in MethoCultw GF H4434.
2.7 Production of GFP containing lentiviruses
and infection of cells
Cells were infected with a lentivirus expressing green fluorescent protein
(GFP) under the control of a cytomegalovirus promoter (pRRL–CMV–
GFP). For the viral production, pRRL–CMV–GFP was co-transfected
with pMDLg-RRE, pRSV-REV, and pCMV-VSVG in HEK293-T cells,
using EZ lentifect (MellGen Laboratories nv). All plasmids were kindly
provided by Dr R.C. Hoeben (University Medical Center, Leiden, The
Netherlands).19
2.8 Cardiomyogenic differentiation assay
The cardiomyogenic differentiation of CASCs and CDCs was first
assessed by mono-culturing these in medium without serum for 1 week
(n ¼ 15). To further stimulate the cardiomyogenic differentiation, GFP-la-
belled cells were co-cultured with primary cultures of neonatal rat CMs
(NRCMs) under comparable conditions (n ¼ 20). For electrophysiology,
GFP expressing CASCs were seeded onto contractile CMs and
co-cultured for 1–3 weeks prior to the recordings.
2.9 RNA extraction and RT–PCR
Total RNA was isolated using the RNeasy Micro kit (Qiagen). In monocul-
tures, cells were lysed by directly adding RNeasy lysis buffer (RLT) buffer
to the tissue culture well after 1 week. In case of co-cultured CASCs,
GFP+ cells were purified from the co-culture by flow sorting directly in
cooled RLT buffer to maintain optimal RNA quality.
2.10 Immunofluorescence
Paraffin-embedded heart tissue sections were deparaffinized and incu-
bated with a primary mouse–anti-human CD34 (Beckton & Dickinson)
and a consecutive goat–anti-mouse FITC (Beckton & Dickinson) antibody.
Hereafter, slides were incubated with a rabbit–anti-human cardiac
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troponin T (cTnT) (Abcam), with a subsequent incubation step of sheep–
anti-rabbit rhodamine-labelled secondary antibody (Millipore).
For the cell cultures, cells were fixed in 4% paraformaldehyde and per-
meabilized with 0.3% Triton X (Sigma-Aldrich). Cells were incubated
overnight with anti-human cTnT and cardiac troponin I (cTnI) rabbit anti-
bodies (Chemicon) followed by incubation with a sheep–anti-rabbit
rhodamine-labelled secondary antibody.
2.11 Electrophysiological recordings
For electrophysiological recordings, mono- and co-cultures were set up as
described above. The whole-cell patch clamp technique was used for
these experiments,20 which were performed at room temperature with
borosilicate glass patch electrodes.
2.12 In vivo differentiation of CASCs
in the Go¨ttingen minipig infarct model
All animal experiments conform with the Directive 2010/63/EU of the
European Parliament.
For these experiments, six Go¨ttingen minipigs (Ellegaard Go¨ttingen mini-
pigs) were used. CASCs were isolated by flow cytometry from the right
atrial appendage of these minipigs removed by right mini-thoracotomy
under general anaesthesia. The animals were sedated by an intramuscular
injection of ketamine (12.5 mg/kg) and midazolam (0.25 mg/kg). Intravenous
access was obtainedwith a 21- or 22-gauge needle in the ear vein and, initial-
ly, anaesthesia was achieved with an intravenous injection of 5 mg propofol.
General anaesthesia was maintained with a continuous infusion of propofol
1% at 10 mL/h and remifentanil (100 mg/mL) at a rate of 5 mL/h. Adequacy
of anaesthesia was observed by standard anaesthesia monitoring, i.e. pulse
oximetry, non-invasive blood pressure, and ECG. The absence of any
stress response was considered as adequate anaesthesia.
Porcine CASCs were isolated using the Aldefluor kitw and expanded ex
vivo under the same conditions as the human-derived CASCs. Before ex-
tensive ex vivo expansion, porcine CASCs were transfected with a lenti-
viral construct containing GFP under the control of the eukaryotic
promoter pEF1a. After ex vivo expansion, GFP+ CASCs were trypsinized
and dissolved in a collagen-matrigelconstruct.21
To study the in vivo differentiation of the autologously transplanted
CASCs, cells were injected intramyocardially after the induction of an
MI. Sedation and anaesthesia of the minipigs was identical as described
above. The heart was exposed through a sternotomy. The left anterior
descending coronary artery was snare occluded for 2 h. Occurrence of
a myocardial infarct was visually confirmed with dark discolouration of
the cardiac muscle, presence of ST-segment elevation on ECG during oc-
clusion, and increased troponin I levels 6 h after the occlusion. After
reperfusion, an average of 18.1+19.6 × 106 CASCs were dissolved
in 400 mL of collagen-matrigel construct and intramyocardially injected
in volumes of 20 mL with a bent 29-gauge needle.
After 2 weeks, the animals were humanely sacrificed. The minipigs were
sedated as described above and euthanized by an intravenous overdose of
propofol (1%). Hearts were excised and examined 2 weeks after trans-
plantation. They were fixed in 4% formalin and processed for immuno-
fluorescent staining as described above.
2.13 Statistics
Throughout the text, continuous variables are displayed as mean+ SD.
For the electrophysiology experiments, the time-dependent currents
(Ito, ICa-L, and/or INa) were measured as the difference between the peak
inward and the steady-state current. Values correspond to mean+ SEM
and were compared using the Mann–Whitney U test.
More detailed protocols can be found in the Supplementary material
online.
3. Results
3.1 The human heart contains an ALDH1
stem-cell population
To investigate the presence of an ALDH+ stem-cell population in the
adult human heart, single-cell suspensions from right atrial appendages
were incubated with Aldefluorw together with antibodies against
CD34, CD45, and c-kit. This antibody combination allowed us to dis-
criminate between mobilized HSCs, which are known to be
ALDH+,22 and potential intrinsic cardiac ALDH+ cells. Flow cyto-
metric analysis showed that an average of 0.9+0.8% of the total
heart cell population expressed high levels of ALDH (Figure 1Ab); of
which 83.8+ 13.4% co-expressed the HSC marker CD34 but
lacked the panleukocyte marker CD45 (Figure 1Ac).
Unexpectedly, the ALDH+CD34+CD452 population or CASCs
turned out to be negative for the previously described CSC marker
c-kit (Figure 1Ca). To investigate more thoroughly whether
ALDH+-CD34+CD452 cells form a distinct cell population, a more
extensive comparison of the antigen expression profile of both cell
populations was performed. In contrast to CASCs, c-kit+ cells, repre-
senting only 0.1+ 0.1% of the total cell population, displayed a low
side scatter (SSC) (Figure 1Ba) and were negative for ALDH
(Figure 1Ca). It should be noted that c-kit+ cells formed a heterogeneous
population that could be divided into two subpopulations. Approxi-
mately half of the c-kit+ cells were negative for CD34 and CD45
(Figure 1Bb) corresponding to the phenotype that has been described
before by Bearzi et al.7 In addition, these cells turned out to be negative
for most markers that were expressed by the CASCs, including CD29,
CD55, andCD73 (Figure 1Cb–d). Amore detailed phenotypic compari-
son between the freshly isolatedCASCs and c-kit+CSCs is listed in Sup-
plementary material online, Table S3. The other c-kit+ subpopulation
expressed CD45 along with CD34 (Figure 1Bb). Hence, these cells
were assumed to be cells of hematopoietic origin.
The phenotypic differences between both cell populationswere con-
firmed by a morphological characterization on flow-sorted CASCs and
c-kit+ cells that were stained with May-Gru¨nwald Giemsa (MGG).
CASCs represented a homogeneous cell population of MNCs charac-
terized by an irregular shape. The nucleus was round to oval, located
peri-centric, and contained some chromatin with vague or clear nucle-
oli. The cytoplasmwas broad, somewhat basophilic without granulation
and contained few vacuoles. The nucleus-to-cytoplasm ratio was small
(Figure 1Ad). In the c-kit+ fraction, mainly two cell types dominated. On
the one hand, large cells with a broad, irregular cytoplasm packed with
large granules showing the typical appearanceofmast cellswerepresent
(Figure 1Bc), confirming the previously reported presence of c-kit+mast
cells in human hearts.13 On the other hand, smaller cells with round,
dark nuclei packed with chromatin structures were detected
(Figure 1Bd). These cells resembled immature cells and were presumed
to be CSCs. In situ analysis of CASCs on heart tissue sections indicated
that just like the c-kit+ CSCs, CASCs were not randomly distributed
throughout the atrium but could be found in so-called stem-cell
niches (Figure 1D) as described previously.7
Since CASCs represent a new population of CSCs, we investigated
whether our cells expressed other cardiac markers like Islet-123 and
the recently described platelet-derived growth receptor alpha,
CD140a.24 In the ALDH+CD34+CD452 population, an average of
30% of the cells was positive for CD140a while expression of this
antigen was not detected in the ALDH2 fraction (see Supplementary
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Figure 1 Flow cytometric and morphologic characterization of cells in right atrial heart tissue. (A) Analysis of ALDH+ cells. Correct ALDH+
gating was achieved by inhibiting ALDH activity by diethylaminobenzaldehyde (DEAB) (a). Without blocking, 0.9+ 0.8% of the total cell population
was ALDH+ (b). Of these cells, 83.8+13.4% expressed CD34 but were CD452 (c). Freshly isolated CASCs stained by May-Gru¨nwald Giemsa
(MGG) showed MNCs with a round to oval nucleus. Their cytoplasm is broad, basophilic, and contains little vacuoles (d). (B) Analysis of c-kit+
cells. 0.1+0.1% of the total cell population expressed CD117 (a). A CD34+/CD45+ and a CD342/CD452 subpopulation were identified (b).
Flow-sorted c-kit+ cells stained by MGG confirmed the presence of two subpopulations. Large cells with a broad cytoplasm and a small
round centrally located nucleus were visible. These cells had the typical appearance of mast cells (c). The second cell population consisted of
smaller cells with round, dark nuclei, and displayed a high nucleus/cytoplasm ratio resembling more immature cells (d). (C) Phenotypic comparison
between ALDH+ cells (pink cell population) and c-kit+ CSCs (blue cell population). In contrast to ALDH+ cells c-kit+ cells were negative for
ALDH (a), CD29 (b), CD55 (c), and CD73 (d). (D) In situ detection of CD34+ cells (green signal; b and d) in atrial heart tissue. Cells are
located in so-called stem-cell niches surrounded by adult cardiomyocytes (red signal; c and d) marked by the expression of cardiac troponin
T. Nuclei are stained with DAPI (blue; a and d).
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material online, Figure S1Ac). Chong et al. reported that the colony-
forming ability used to examine the clonality of the cells was restricted
to the CD140a+ population. However, we could neither detect any dif-
ference in number nor in size of the clones between ALDH+-CD140a+
and ALDH+CD140a2 sorted cell fractions (data not shown). In contrast,
the other cardiac marker, Islet-1, is uniformly expressed in CASCs and
CDCs as shown by immunofluorescence (see Supplementary material
online, Figure S1B). When flow-sorted CASCs were expanded ex vivo,
their phenotype changed drastically. The expression of several antigens
including CD13, CD44, and CD49c was induced while the expression
of CD34 was down-regulated (see Supplementary material online,
Table S4). As a consequence, ex vivo expanded CASCs evolved towards
an antigen expression profile that resembled CDCs (see Supplementary
material online, Table S5) or c-kit+ CSCs after culturing.7,15,25 Despite
the fact that ex vivo expanded CASCs lost expression of the CD34
stem-cell marker, Islet-1 and the ALDH activity of these cells persisted
at least until cell passage 10 (see Supplementary material online,
Figures S1B and S2).
The elevated ALDH activity in combination with the expression of
the stem-cell marker CD34 suggests that CASCs probably possess
stem-cell characteristics. To test their clonogenicity, a single-cell sort
experiment was performed in which 3456 GFP-labelled CASCs were
sorted directly in 96-well plates. Single cell disposition was microscop-
ically analysed and wells with more than one cell were excluded. After 5
days, 582 clones were counted resulting in a clonogenicity of 16.8+
11.4% (Figure 2A). In addition, freshly isolated as well as ex vivo expanded
CASCs expressed pluripotency-associated genes like Oct-4, Nanog,
c-Myc, Klf4 lin-28, DPPA3, and Tbx3. However, no expression of Sox-2
could be detected (Figure 2B). Hence, CASCs can be expanded ex vivo
without losing important stem-cell characteristics.
3.2 CASCs are phenotypically and
functionally different from BM stem cells
Since high levels of ALDH expression have been described in stem
cells from peripheral blood (PBL) and BM,16,22 we investigated
whether CASCs were not representing mobilized HSCs or MSCs.
The antigen expression profile of ALDH+ cells derived from BM or
PBL differed noticeably from CASCs. In BM, 85.2+10.1% of
ALDH+ cells (1.2+0.4%) expressed CD34 and were uniformly posi-
tive for CD45 but negative for CD73 (see Supplementary material
online, Figure S3Aa–c). Similarly, PBL ALDH+ cells (0.8+ 0.8%)
were all positive for CD45 but negative for CD34 and CD73 (see
Supplementary material online, Figure S3Ad–f). Moreover, CASCs
did not possess the typical functional properties attributed to HSCs
or MSCs. For the analysis of the hematopoietic function, freshly iso-
lated BM- and heart tissue-derived ALDH+ cells were seeded in
medium containing growth factors stimulating HSC cell growth and
differentiation. After 2 weeks, CASCs did not grow in these condi-
tions and remained visible as single cells (see Supplementary material
online, Figure S3Bb) whereas BM-derived ALDH+ cells formed typical
haematological colonies including BFU-E, CFU-GM, and CFU-GEMM
(see Supplementary material online, Figure S3Ba). To determine mes-
enchymal characteristics, BM and heart tissue-derived ALDH+ cells
were isolated, expanded ex vivo under identical culture conditions,
and finally forced to differentiate down the adipogenic and osteogenic
lineage. In these conditions, BM-derived ALDH+ cells displayed either
the typical round morphology of adipocytes containing numerous fat
droplets positively stained red with oil-red O (see Supplementary
material online, Figure S3Bc) or differentiated to osteocytes as
shown by a positive alizarin-red staining of Ca2+-deposits (see Supple-
mentary material online, Figure S3Be). In contrast, CASCs displayed no
signs of adipogenic (see Supplementary material online, Figure S3Bd)
or osteogenic differentiation (see Supplementary material online,
Figure S3Bf). Instead, they looked more hypertrophied and demon-
strated thick actin bands in the cytoplasm, indicating a more senescent
state which was not found in normal ex vivo expansion conditions.
These results suggest that CASCs are probably not mobilized stem
cells from BM.
3.3 CASCs display better cardiomyogenic
differentiation than CDCs
To evaluate the differentiation potential of CASCs, their cardiomyo-
genic differentiation was compared with that of CDCs. For technical
and practical reasons, only CDCs were implemented in this compara-
tive assay. Besides, earlier findings showed an equivalent cardiac differ-
entiation potential as c-kit+ CSCs.15 Initially, cells were monocultured
in low serum conditions to stimulate spontaneous cardiomyogenic dif-
ferentiation. This resulted only in a partial cardiac phenotype shown
by the uniform expression of the CM transcription factor GATA-4,
the structural proteins Troponin T (TnT) and a-actinin, the gap-
junctional protein Cx43 as well as two ion channels, more specifically
the potassium voltage-gated channel Kv4.3 and the L-type calcium
channel subunit a1c. The expression of myosin heavy chain (MHC)
was not observed (Figure 3A). Although monocultured cells expressed
TnT, the corresponding protein was not translated (data not shown).
However, when GFP-labelled cells were brought in a cardiac micro-
environment by co-culturing them with neonatal rat CMs (NRCMs),
cardiomyogenic differentiation improved but it was much more pro-
nounced in CASCs. In addition to the expression of TnT, a-actinin,
Cx43, Kv4.3, a1c, and GATA-4, both cell types also expressed MHC
after 1 week of co-culturing (Figure 3A) as reported earlier for
CDCs.15 However, the superior cardiac differentiation of CASCs
compared with CDCs was clearly shown at the protein level by the
expression of sarcomeric-organized cTnT (Figure 3Ba–d) and cardiac
troponin I (cTnI) proteins (Figure 3C). In the same experimental
setup, CDCs only expressed cTnT (Figure 3Be–h) but expression of
cTnI could not be observed (data not shown). These observations
are consistent with our previously reported data on cardiomyogenic
differentiation of CSCs and CDCs.15 Interestingly, some contracting
CASCs could be observed in co-culture while this phenomenon
was never noticed with CDCs (see Supplementary material online,
Movie S1).
As CASCs showed a complete genetic and phenotypic cardiac
profile, their electrophysiological properties were investigated by
voltage-clamp experiments. Figure 4a shows a time-dependent
current measured with step depolarizations from a holding potential
of 280 mV. Mean data (n ¼ 5) of peak and end-of-pulse current
(Figure 4B) show that time-dependent currents were activated at
potentials above 250 mV and suggest the presence of the
transient-outward K+ current (Ito). This current was recorded in
22% (5 out of 23 cells) of differentiated CASCs. Following a first
voltage step to various levels (Figure 4C and D), the membrane was
depolarized in a second step to +60 mV to test for the amplitude of
the current that was not inactivated during the first step. The
measurements were carried out in the absence or presence of
4-aminopyridine (4-AP), which is known to block Ito. The time-decaying
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component present under control conditions (Figure 4C) was sup-
pressed in the presence of 4-AP (Figure 4D), whereas the time-
dependent current measured at negative potentials (largely represent-
ing IK1) remained unaffected. The inactivation curve obtained by plot-
ting the time-dependent current during the second voltage step as a
function of the potential during the first step is typical of Ito
(Figure 4E). In some cells, largely inactivating Ito by a pre-pulse to
250 mV allowed visualization of an outward current at +50mV,
which resulted in a tail current upon repolarization to 210 mV
(Figure 4F). This result is consistent with the presence of the delayed
rectifier K+ current IK, but no pharmacological tool was applied to
provide a clearer current separation of Iks and Ikr. Inward currents acti-
vated upon depolarization were detectable in 34.78% of the cells (8 out
of 23 cells). The inward currents typically decayed slowly due to inacti-
vation (Figure 5A) and the current–voltage relation was bell-shaped
with a maximum current occurring at 210 mV (Figure 5B). These are
typical characteristics of ICa-L (n ¼ 5). Although no pharmacological
test was applied to ascertain the nature of the channel involved, the
amplitude of the current increased following the application of isopro-
tenerol (data not shown). In three additional cells, inward current was
activated upon depolarization with kinetics that were too fast to be
accounted by ICa-L (Figure 5C). In this case, the voltage of maximum
Figure 3 Cardiomyogenic differentiation potential. (A) RT–PCR analysis of cardiac specific genes. Lane 1: mono-cultured CASCs; lane 2:
co-cultured CASCs; (+): positive control (human cardiomyocytes); 2: negative control. Mono- and co-cultured CASCs expressed GATA-4, TnT,
a-actinin, Connexin43 (Cx43), Kv4.3, and a1c. Co-culturing CASCs induced the expression of MHC. (B) Immunofluorescence of TnT on co-cultured
CASCs and CDCs. Co-culturing GFP+ CASCs induced the expression of TnT in CASCs (a–d) and CDCs (e–h) in a sarcomeric organization resem-
bling adult cardiomyocytes. (C ) Immunofluorescence of TnI on co-cultured CASCs. After 1 week of co-culture with NRCMs GFP+ CASCs (green;
b and d) express TnI (red; c and d) in a sarcomeric fashion as expected in adult cardiomyocytes.
Figure 2 Stem-cell characteristics of freshly isolated and ex vivo expanded CASCs. (A) Clonogenicity of ex vivo expanded CASCs. GFP+ CASCs were
sorted with a density of 1 cell/well under stringent purity conditions. Single-cell disposition was confirmed by fluorescent microscopy. After 5 days,
582 clones were counted resulting in a clonogenicity of 16.8+11.4%. (B) RT–PCR for the expression of pluripotency associated genes. Lane 1: freshly
isolated CASCs; lane 2: ex vivo expanded CASCs. (2): negative control; M: marker. CASCs uniformly express Oct-4, NANOG, C-myc, Klf4, lin-28, DPPA3,
and Tbx3. No expression of SOX-2 could be detected in any condition.
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current was also more negative (less than220 mV; Figure 5D), suggest-
ing the presence of either voltage-dependent Na+ current (INa) or of
the transient Ca2+ current (ICa-T). The presence of voltage-activated
inward and outward currents suggested that these cells would be
able to display action potentials. All cells had a depolarized resting
membrane potential and stimulation under current clamp conditions
resulted in a depolarization followed by a slow repolarization (see Sup-
plementary material online, Figure S4). Although no maintained plateau
was recorded, the response is suggestive of a slow action potential.
Besides these currents and slow action potentials showing
differentiation of the co-cultured CASCs towards a CM phenotype,
the size of differentiated CASCs increased relative to that of the mono-
cultured CASCs (see Supplementary material online, Figure S5). Cell
membrane capacitance of co-cultured CASCs ranged from 64.9 to
314.4 pF, with a mean value of 142.7+ 16.3 pF (n ¼ 36) (see Supple-
mentary material online, Figure S5, insert). This was significantly
higher than the capacitance of NRCMs (41.3+5.0 pF, n ¼ 14; P,
0.0001) or mono-cultured CASCs (86.5+10.3 pF, n ¼ 30; P ¼
0.001). Thus, capacitance of co-cultured CASCs corresponds to that
of mature human cardiac cells.
Figure 4 Voltage-activated K+ currents in co-cultured CASCs. Transient outward current (Ito; A–E). Traces of time-dependent outward currents
activated by 100-ms depolarizations from the holding potential (A). Means and SEM of currents measured at peak level (unfilled circles) and at the end
of the voltage steps (filled circles) (B). Currents activated by 1-s depolarizations and tails currents recorded during a second step to +60 mV, in the
absence (control) or presence of 50 mM 4-AP, respectively (C and D). Availability (or inactivation) curves obtained by plotting the relative magnitude
of the tails recorded at +60 mV as a function of the potential during the first voltage step. Data from (C) and (D) (E). Depolarization-activated delayed
rectifier current (F ). After largely inactivating Ito by a pre-pulse to –50 mV, cells were depolarized to +50 mV to activate both IKr and IKs currents
followed by a repolarization to 210 mV to deactivate IKs.
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3.4 In vivo engraftment and differentiation
of autologous CASCs
An average of 31.018+ 15.853 CASCs were isolated from the right
atrial appendages of the minipigs (see Supplementary material
online, Figure S6). After ex vivo expansion, an average of 18.1+
19.6 × 106 autologous cells was intramyocardially transplanted in
the peri-infarct zone of an acute MI model.
Immunofluorescence showed successful engraftment after 2 weeks
(Figure 6A and B). Extensive differentiation of the GFP+ CASCs could
be detected by the expression of cTnT (Figure 6C and D). Importantly,
there were no signs of teratoma formation after this follow-up.
4. Discussion
In this paper, we report the existence of a new stem-cell population
present in human heart tissue. Since these cells display a unique
phenotype, they were named CASCs, after the location where they
were first identified. CASCs are mainly characterized by a high
ALDH activity, the expression of CD34, and the lack of CD45 and
c-kit expression. Despite the previously described potential of
CSCs and CDCs to adopt a cardiomyogenic phenotype,7,11,15 in
our hands the isolation and ex vivo expansion of CASCs was more
reliable and reproducible compared with c-kit+ CSCs. Moreover, in
comparison with CDCs, they showed superior cardiac differentiation
capacities.
This is the first time that the presence of an ALDH+ cell population
is reported in the human heart. The choice of an enzymatic reaction
as an isolation marker for stem cells from human cardiac tissue was
actually inevitable as the current isolation methods fall short for
reasons discussed in detail in this paper. The major advantages of
using an enzymatic reaction for cell detection are that a viable and
more homogeneous population can solely be isolated compared
with isolations based on the antigen–antibody interaction. Indeed,
histological comparison between flow-sorted CASCs and c-kit+
CSCs demonstrated the heterogenic character of the c-kit+ popula-
tion in contrast to the sorted CASCs. This heterogenic cell population
and the presence of bound antibody on the cell membrane probably
explain the poor efficiency and reproducibility that we encountered
during the ex vivo expansion of c-kit+ CSCs.
Meanwhile, it is well known that ALDH activity is a feature shared
by several stem-cell types including HSCs and MSCs. Despite the simi-
larity with these cell types, we showed that CASCs constitute an in-
dependent cell population with a unique phenotype not displaying the
typical HSC and MSC functional characteristics. Despite these convin-
cing results, the origin of CASCs still has to be determined. Indeed, it
remains unclear whether these cells are already present in the foetal
heart or are mobilized to the heart after birth and have resided there
long enough to adopt a more cardiac committed phenotype. The fact
Figure 5 Voltage-activated inward currents in co-cultured CASCs. Trace of current elicited by a 500-ms depolarization from the holding potential
of 280 to 0 mV (A). Current–voltage relation from experiments such as those of (A; n ¼ 5), using steps to potentials ranging from 260 to +50 mV in
10-mV steps, suggesting the presence of ICa (B). Trace of fast-decaying inward current elicited by a 100-ms depolarization from the holding potential of
280 to 230 mV (C). Current–voltage relation from traces such as those of (C; n ¼ 3) using steps to various potentials, suggesting the presence of INa
or ICa-T. In the current–voltage relations (B and D), current amplitudes were normalized to cell size (current density values, pA/pF) and plotted against
test voltages (mV).
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that CASCs express the typical cardiac marker islet-1 favours the first
assumption.
Why high ALDH activity is associated with stem-cell properties is
still unknown. In vivo ALDH metabolizes aldehydes to their corre-
sponding carboxylic acids26 and supports the mechanisms of resist-
ance to alkylating agents, e.g. cyclophosphamide.22,27 Hence a
detoxifying role is ascribed to ALDH and cells expressing this
enzyme are better protected against certain cytotoxic effects.22,28
This latter property makes the CASC a perfect candidate for cell ther-
apies in ischaemic-induced diseases. In addition, flow cytometric ana-
lysis revealed that these cells were also positive for CD34. Although
CD34 was initially used as a HSC-specific marker, expression of this
antigen has recently been identified on other tissue-specific cells, e.g.
muscle satellite cells29–31 and, as shown in this paper, also on CASCs.
It has become clear that CD34 is important to enhance proliferation
and to block differentiation of stem cells.32 In addition, functions im-
plying chemokine-mediated trafficking and regulation of asymmetric
cell division are also ascribed to this marker.33 Nielsen et al. suggested
that stem-cell factor and stromal-derived factor, which are both pro-
duced as a consequence of myocardial ischaemia, are chemo-attrac-
tants for CD34+ cells. We postulate that CASCs may be activated
after an ischaemic insult, migrate towards the site of injury and fulfil
a protective role. This last assumption is based on the expression
of CD73 on CASCs. This 5′-nucleotidase accounts for the rapid con-
version of free AMP, which accumulates during ischaemia, into adeno-
sine. It restores the unbalance between the oxygen demand and
supply of the heart through its vasodilatory and anti-adrenergic
effects.34 Taken together, all arguments are in favour for the existence
of a non-hematopoietic CD34+/CD73+ stem-cell population in the
human heart.
Very recently, a new marker for stem cells of cardiac origin has
been described: the platelet-derived growth factor receptor also
known as CD140a.24 Since CASCs did not show any similarity with
heart stem cells described until now, we wondered whether there
was any relationship with this new cCFU-F stem-cell population.
Indeed, we found that 30% of freshly isolated ALDH+CD34+CD452
cells also expressed this epicardial stem-cell marker while no
CD140a+ cells were detected in the ALDH2 fraction. Despite this
finding, CFU-F formation was not restricted to the CD140a subfrac-
tion since ALDH+CD140a2 cells had an equal colony-forming ability.
In the mouse model, expression of CD140a is restricted to stem cells
of epicardial origin and only these cells possess a colony-forming
ability. Based on our findings, we conclude that ALDH+ heart cells
are probably part of the cCFU-F stem-cell hierarchy. According to
the hematopoietic model of Christ et al., ALDH activity decreases
during HSCs differentiation.35 If this model can be extrapolated to
CSCs, CASCs would be situated in a more immature state compared
with CD140+ cells. In support of this theory, CASCs express several
pluripotency-associated genes like Oct-4, Nanog, c-Myc, Klf4, lin-28,
DPPA, and Tbx3 which are not detected in cCFU-F stem cells. In add-
ition, the ALDH+/CD140a2 cell fraction possess an equal cCFU-F
potential, indicating the presence of multipotent progenitors in this
cell fraction.
Since MI results in a massive loss of CMs, replacement by func-
tional tissue is one important aspect of a future treatment. Cardio-
myogenic differentiation of ex vivo expanded CASCs could only be
accomplished by co-culturing these cells with NRCMs, underscoring
the importance of a cardiac micro-environment. Early in co-culture,
expression of several cardiac-specific genes like TnT, MHC, a-actinin
was detected, which was followed by cTnT and cTnI protein
Figure 6 Immunofluorescent analysis on heart slices from CASC transplanted Go¨ttingen minipigs. (A) Two weeks after transplantation, large areas
of GFP+ CASCs (green) could be detected in the peri-infarct region visible as the border between viable cardiomyocytes, cTnT-positive (red) and
cTnT-negative cells, blue nuclei (DAPI). (B) Between the viable cardiomyocytes (cTnT+; red), clusters of GFP+ cells (green) are visible. (C and D)
Closer examination of the GFP+ cells (green) demonstrated differentiation towards cardiomyocytes as shown by positive cTnT staining (red).
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detection in a sarcomeric organization typical for adult CMs. While
co-cultured CASCs displayed almost no ion currents after 1 week,
prominent inwardly rectifying and voltage-dependent currents
started to develop after 8–10 days. Over time, CASCs differentiated
towards an adult CM phenotype as ultimately shown by the pres-
ence of ICa, INa, Ito, Ik, and Ik1. Furthermore, the responsiveness to
pharmacological drugs like isoprotenerol and 4-AP is of great im-
portance since it demonstrates the presence of functional receptors
on differentiated CASCs. The detection of contracting CASCs in
co-culture confirmed these results. Cardiac differentiation results
of CASCs were far better than those of CDCs since with the
latter cells no cTnI could be detected during previous and present
in vitro differentiation experiments.15 The limited cardiac differenti-
ation of these CDCs in our experiments could maybe explain the
outcome results of the recently published CADUCEUS trial.12
This proof-of-concept study showed an increase in viable myocar-
dium and, related to this, a decrease in scar size and mass.
However, the study failed to detect an increase in left ventricular
ejection fraction. Unfortunately, the authors were not able to inves-
tigate whether the intracoronary transplanted CDCs homed in the
peri-infarcted area of the heart and differentiated to functional
adult CMs. The authors claimed that the indirect effect of the trans-
plantation could be more important than the direct differentiation of
CDCs to improve cardiac function. Using CASCs for myocardial re-
generation may resolve the problem of no direct or complete cell
differentiation. Indeed, our in vivo experiments demonstrated that
after the intramyocardial transplantion of autologous CASCs, these
cells were able to survive and engraft in an acute setting of the
Go¨ttingen minipig infarct model. Immunofluorescent analysis of tissue
slices revealed excellent engraftment of CASCs in the porcine heart 2
weeks after transplantation. A substantial number of the engrafted
cells differentiated already towards the cardiomyogenic lineage as
shown by a positive staining for cTnT in GFP+ cells. The survival and dif-
ferentiation in this very hostile environment of inflammation and fibrosis
during the acute phase after the MI proved the potency of the CASCs.
However, one should be aware that the engraftment, survival, and dif-
ferentiation of the CASCs could be positively influenced by the colla-
gen–matrix used for cell injection. Furthermore, despite no signs of
teratoma formation could be detected during our observation period,
the expression of the pluripotency-associated genes requires a more
thorough safety study of the cells, for example in an SCID–mouse
model with a longer follow-up. These preliminary data are very prom-
ising for potential use of CASCs in a clinical setting. However, a larger
preclinical study confirming these results in combinationwith functional
data will be necessary to prove the real potential of the CASCs. In con-
clusion, we identified a new intrinsic CSCs population that is mainly
characterized by high ALDH expression and the presence of CD34
on the plasma membrane. Cells can be expanded ex vivo without loss
of their pluripotency characteristics and are able to differentiate
down the cardiomyogenic lineage in vitro as well as in vivo. The discovery
of this CASC population opens new perspectives for regeneration of
the infarcted heart.
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